Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?

J Urol. 2015 Jun;193(6):1882-3. doi: 10.1016/j.juro.2015.03.070. Epub 2015 Mar 17.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Diabetes Mellitus / chemically induced*
  • Diabetes Mellitus / epidemiology*
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Humans
  • Male
  • Metabolic Syndrome / chemically induced*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Gonadotropin-Releasing Hormone